Drugs that contain Pemetrexed
1. Pemfexy patents expiration
PEMFEXY's oppositions filed in EPO
PEMFEXY Litigations
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance. | ||||
| US9604990 | EAGLE PHARMS | Crystalline forms of pemetrexed diacid and manufacturing processes therefor |
Oct, 2035
(11 years from now) | |
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7772209 | EAGLE PHARMS | Antifolate combination therapies |
May, 2022
(1 year, 10 months ago) | |
| US11793813 | EAGLE PHARMS | Pemetrexed formulations |
Feb, 2036
(11 years from now) | |
Market Authorisation Date: 08 February, 2020
Treatment: Use of pemetrexed with prior and/or repeated vitamin b12 and folic acid administration in patients with non-squamous non-small cell lung cancer
Dosage: SOLUTION;INTRAVENOUS
More Information on Dosage
PEMFEXY family patents
